StockNews.AI
ACLS
StockNews.AI
9 hrs

Axcelis Announces the Launch of the Company's New Purion Power Series+ Ion Implant Platform Designed for Next Generation SiC Power Devices

1. Axcelis launched the Purion Power Series+ for semiconductor devices. 2. The product boosts device performance and productivity for power applications. 3. It includes multiple platform extensions for various energy applications. 4. The series supports diverse wafer sizes and substrate types with high efficiency. 5. Axcelis aims to lead in ion implant solutions for emerging technologies.

6m saved
Insight
Article

FAQ

Why Bullish?

The introduction of innovative products typically strengthens company's market position. Historical precedents show that new product launches can lead to stock price increases, as seen with other tech companies after introducing groundbreaking technologies.

How important is it?

The product's launch is significant for ACLS's market strategy and potential revenue growth, especially as demand for semiconductors rises. The prominence of their new technologies makes this news critical for current and prospective investors.

Why Long Term?

While initial reactions may be positive, sustained growth relies on the adoption of these new technologies in the semiconductor industry, which can take time to materialize. For example, Intel's new processor lines often take 1-2 years to significantly impact stock prices after release.

Related Companies

INTCNVDAAMD
, /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, has announced the launch of the Company's new Purion Power Series+™ ion implant product platform, designed specifically to enable improved device performance and increase productivity for next generation power devices, including emerging superjunction architectures. Axcelis' new Purion Power Series+™ ion implant product platform is designed specifically to enable improved device performance and increase productivity for next generation power devices, including emerging superjunction architectures. The new Purion Power Series+ covers the full ion implant market space with new product line extensions and upgrades that include the Purion H200+ SiC for high current medium energy applications, Purion M+ SiC for medium current applications and the Purion XE+ SiC and Purion EXE+ SiC for high energy applications.  Executive Vice President Dr. Greg Redinbo, commented, "We're excited to launch the Company's new Purion Power Series+ platform. Axcelis has a long history of collaborating closely with our customers to develop innovative solutions for their high value challenges. The Purion Power Series+ family is uniquely suited to address these challenges due to its innovative platform that offers the flexibility to handle multiple wafer sizes (150mm and 200mm), substrate types (including SiC, Si, GaN, and GaAs wafers) and implant temperatures (room temperature, warm and hot). This is accomplished while also delivering the industry's highest throughput and capital efficiency." President and CEO Dr. Russell Low, said, "We are proud to be the innovation and market leader in ion implantation solutions for power devices. Axcelis was first to market with a full portfolio of implanters with innovative capabilities specifically to address high volume manufacturing needs for the power device industry. Evolving power device roadmaps are now driving the rapid transition to new technical and production requirements. Axcelis' Purion Power Series+ Platform is the next generation of ion implant solutions designed specifically to meet these challenges across the full spectrum of existing and emerging applications."About Axcelis:Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.CONTACTS:Press/Media Relations Contact: Maureen HartSenior Director, Corporate & Marketing CommunicationsTelephone: (978) 787-4266Email: [email protected] Investor Relations Contact:David RyzhikSenior Vice President, Investor Relations and Corporate StrategyTelephone: (978) 787-2352Email: [email protected] SOURCE Axcelis Technologies, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News